Copyright
©The Author(s) 2020.
World J Gastroenterol. Aug 21, 2020; 26(31): 4624-4638
Published online Aug 21, 2020. doi: 10.3748/wjg.v26.i31.4624
Published online Aug 21, 2020. doi: 10.3748/wjg.v26.i31.4624
Table 4 Pathologic response
| Variable | Interval ≤ 9 wk | Interval > 9 wk | P value |
| (group A, n = 139) | (group B, n = 92) | ||
| No downstaging, TNM (n, %) | 83 (59.7) | 35 (38) | 0.001 |
| Downstaging, TNM (n, %) | 41 (29.5) | 32 (34.8) | 0.129 |
| T, n (%) | 0.016 | ||
| No downstaging | 83 (59.7) | 52 (56.5) | |
| Downstaging | 56 (40.3) | 40 (43.5) | |
| N, n (%) | 0.010 | ||
| No downstaging | 100 (71.9) | 51 (55.4) | |
| Downstaging | 39 (28.1) | 41 (44.6) |
- Citation: Mei SW, Liu Z, Wei FZ, Chen JN, Wang ZJ, Shen HY, Li J, Zhao FQ, Pei W, Wang Z, Wang XS, Liu Q. Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients. World J Gastroenterol 2020; 26(31): 4624-4638
- URL: https://www.wjgnet.com/1007-9327/full/v26/i31/4624.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i31.4624